We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Published in Oncology

Journal Scan / Research · October 05, 2012

Regimen Shows Front-Line Promise in Advanced Pancreatobiliary Cancers

American Journal of Clinical Oncology

 

Additional Info

American Journal of Clinical Oncology
Optimizing the Administration of Fixed-Dose Rate Gemcitabine Plus Capecitabine Using an Alternating-Week Schedule: A Dose Finding and Early Efficacy Study in Advanced Pancreatic and Biliary Carcinomas
Am. J. Clin. Oncol 2012 Oct 01;35(5)411-417, AH Ko, AM Espinoza, KA Jones, et al

Further Reading